FDA issued a Warning Letter to SCA Pharmaceuticals on 6/25/2015 as a result of this inspection.
FDA investigators audited the SCA Pharmaceuticals - Little Rock, AR, United States facility and issued 8 inspectional observations (via FDA 483) on 02 Apr 2014.
Add To Cart
- Category: Human Drugs
- Number of Observations: 8
- Inspection end: 02 Apr 2014
- Location: Little Rock, United States
- FEI: 3010683157